Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F (2003) Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide Biol Chem 8:15–25
CAS
Article
Google Scholar
Advani N, Sastroasmoro S, Ontoseno T, Uiterwaal CS (2018) Long-term outcome of coronary artery dilatation in Kawasaki disease. Annals of pediatric cardiology 11:125–129
Article
Google Scholar
Chen PT, Lin MT, Chen YS, Chen SJ, Wu MH (2017) Computed tomography predict regression of coronary artery aneurysm in patients with Kawasaki disease, Journal of the Formosan Medical Association = Taiwan yi zhi. 116:806–814
Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH (2016) Progressive coronary dilatation predicts worse outcome in Kawasaki disease. J Pediatr 171:78–82 e71
Article
Google Scholar
Dietz SM, Kuipers IM, Koole JCD, Breur J, Fejzic Z, Frerich S, Dalinghaus M, Roest AAW, Hutten BA, Kuijpers TW (2017) Regression and complications of z-score-based giant aneurysms in a Dutch cohort of Kawasaki disease patients. Pediatr Cardiol 38:833–839
CAS
Article
Google Scholar
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5
Fujii M, Tanaka H, Nakamura A, Suzuki C, Harada Y, Takamatsu T, Hamaoka K (2016) Histopathological characteristics of post-inflamed coronary arteries in Kawasaki disease-like vasculitis of rabbits. Acta Histochem Cytochem 49:29–36
CAS
Article
Google Scholar
Fukushige J, Takahashi N, Ueda K, Hijii T, Igarashi H, Ohshima A (1996) Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 17:71–76
CAS
Article
Google Scholar
Han CL, Zhao SL (2018) Intravenous immunoglobulin gamma (IVIG) versus IVIG plus infliximab in young children with Kawasaki disease. Medical science monitor : international medical journal of experimental and clinical research 24:7264–7270
CAS
Article
Google Scholar
JCS Joint Working Group (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Circ J 78:2521–2562
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. CIR 94:1379–1385
CAS
Google Scholar
Liu MY, Liu HM, Wu CH, Chang CH, Huang GJ, Chen CA, Chiu SN, Lu CW, Lin MT, Chang LY, Wang JK, Wu MH (2017) Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease. BMC Pediatr 17:139
Article
Google Scholar
Manlhiot C, Niedra E, McCrindle BW (2013) Long-term management of Kawasaki disease: implications for the adult patient. Pediatrics and neonatology 54:12–21
Article
Google Scholar
McNeal-Davidson A, Fournier A, Scuccimarri R, Dancea A, Houde C, Bellavance M, Dahdah N (2013) The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the province of Quebec: the complete series since 1976. Pediatr Cardiol 34:170–178
Article
Google Scholar
Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111:38–43
CAS
Article
Google Scholar
Mueller F, Knirsch W, Harpes P, Pretre R, Valsangiacomo Buechel E, Kretschmar O (2009) Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions. Clinical research in cardiology : official journal of the German Cardiac Society 98:501–507
Article
Google Scholar
Murphy DJ Jr, Huhta JC (1987) Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 316:881
Article
Google Scholar
Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, Jain S, Silverstein L, Baker AL, Tanaka N, Ogihara Y, Ikehara S, Takatsuki S, Sakamoto N, Kobayashi T, Fuse S, Matsubara T, Ishii M, Saji T, Newburger JW, Burns JC (2013) Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol 168:3825–3828
Article
Google Scholar
Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarevian JP, Perlman EJ, Trevenen C, Rotta AT, Kalelkar MB, Rowley AH (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7:e38998
CAS
Article
Google Scholar
Ronai C, Hamaoka-Okamoto A, Baker AL, de Ferranti SD, Colan SD, Newburger JW, Friedman KG (2016) Coronary artery aneurysm measurement and Z score variability in Kawasaki disease. J Am Soc Echocardiogr 29:150–157
Article
Google Scholar
Samada K, Shiraishi H, Sato A, Momoi MY (2010) Grown-up Kawasaki disease patients who have giant coronary aneurysms. World journal of pediatrics : WJP 6:38–42
Article
Google Scholar
Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. CIR 75:387–394
CAS
Article
Google Scholar
Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H (2018) Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China. Clin Rheumatol 37:1945–1951
Article
Google Scholar
Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H, Yoshibayashi M (2014) A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J 167:249–258
Article
Google Scholar
Tsuda E, Tsujii N, Hayama Y (2017) Cardiac events and the maximum diameter of coronary artery aneurysms in Kawasaki disease. J Pediatr 188:70–74.e71
Article
Google Scholar